Dr. Ying-Chun Lo, a lung pathologist, and Dr. Konstantinos Leventakos, a medical oncologist, talk about why
biomarker testing is important for patients with
lung cancer and what to do if it has not yet been offered by your doctor. Dr. Lo describes how biomarker testing helps your healthcare team understand the
unique characteristics of your lung cancer and allows them to
identify the most effective treatment for you. He explains that this approach is called
personalized medicine. Dr. Leventakos elaborates further that treatment for lung cancer is not "one size fits all", and that biomarker testing for NSCLC will help your healthcare team to
personalize your treatment. If biomarker testing has not yet been offered to you, feel free to discuss it with your doctor.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.